TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 104 filers reported holding TG THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,599,000 | -42.2% | 399,949 | +1.3% | 1.14% | +4.7% |
| Q3 2021 | $13,144,000 | -18.3% | 394,949 | -4.8% | 1.09% | -16.1% |
| Q2 2021 | $16,096,000 | -35.0% | 414,949 | -19.2% | 1.30% | -30.6% |
| Q1 2021 | $24,758,000 | +130.4% | 513,649 | +148.7% | 1.88% | +148.0% |
| Q4 2020 | $10,745,000 | +803.7% | 206,549 | +105.8% | 0.76% | +394.8% |
| Q3 2017 | $1,189,000 | +45.5% | 100,366 | +23.5% | 0.15% | +71.9% |
| Q2 2017 | $817,000 | -49.0% | 81,266 | -40.9% | 0.09% | -52.4% |
| Q1 2017 | $1,602,000 | -87.6% | 137,500 | -91.0% | 0.19% | -70.2% |
| Q1 2016 | $12,965,000 | -28.6% | 1,521,667 | 0.0% | 0.63% | -19.0% |
| Q4 2015 | $18,153,000 | +23.0% | 1,521,667 | +3.9% | 0.77% | +14.5% |
| Q3 2015 | $14,758,000 | +15.2% | 1,464,105 | +89.6% | 0.68% | +26.6% |
| Q2 2015 | $12,808,000 | +89.7% | 772,017 | +77.0% | 0.53% | +108.6% |
| Q1 2015 | $6,751,000 | – | 436,084 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |